countdown to test result, page-7

In my opinion it will be a year to get through these tests and start Phase II trial, and that assumes all goes well in them.

However, the Annual Report ("Other Technology/Applications" Page 6) clearly indicates that they are looking at other products, including additional uses for Coramasine, in order "to expand Solbec's product pipeline".

So I believe there is some hope that other things will emerge during the period while the preclynical tests are conducted.

Personally, I am a long term holder of this stock. It is extremely high risk on the one hand, but on the other there are some historical indications that "they've got something". But DYOR!!!!

Barley